Share on StockTwits

Several investment firms have updated their stock ratings and price targets on shares of Groupon (NASDAQ: GRPN) in the last week:

  • Groupon had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $9.00 price target on the stock, down previously from $10.00.
  • Groupon had its price target lowered by analysts at Piper Jaffray from $16.00 to $10.00. They now have an “overweight” rating on the stock.
  • Groupon had its price target lowered by analysts at Wunderlich from $10.00 to $6.00. They now have a “hold” rating on the stock.
  • Groupon had its “neutral” rating reaffirmed by analysts at Credit Suisse. They now have a $6.50 price target on the stock, down previously from $10.00.
  • Groupon had its price target lowered by analysts at RBC Capital from $6.00 to $5.00. They now have an “underperform” rating on the stock.
  • Groupon had its “buy” rating reaffirmed by analysts at Deutsche Bank. They now have a $7.00 price target on the stock, down previously from $8.00.
  • Groupon had its “neutral” rating reaffirmed by analysts at Macquarie. They now have a $6.50 price target on the stock, down previously from $7.00.
  • Groupon had its price target lowered by analysts at Jefferies Group from $8.00 to $7.00.
  • Groupon had its price target lowered by analysts at Northland Securities from $7.00 to $6.00. They now have an “in-line” rating on the stock.
  • Groupon had its price target lowered by analysts at Evercore Partners to $5.50. They now have an “equal weight” rating on the stock.
  • Groupon had its price target lowered by analysts at Bank of America to $7.50.
  • Groupon had its price target lowered by analysts at B. Riley from $9.50 to $8.50.
  • Groupon had its “neutral” rating reaffirmed by analysts at Zacks. They now have a $6.25 price target on the stock. Zacks‘ analyst wrote, “Groupon reported mixed second-quarter 2014 results. Loss of $0.02 was narrower than the Zacks Consensus Estimate of a loss of $0.04. However, revenues missed the Zacks Consensus Estimate. Management lowered full-year EBITDA guidance. The lowered guidance reflects ongoing investments which will continue to hurt the company’s profitability going forward. Moreover, the company continues to face stiff competition in North America which is a major headwind. Additionally, the Genome offering will bring Groupon into direct competition with the likes of Verifone, MICROS and Salesforce, which in turn is a major concern. Nonetheless, we believe that Groupon is well positioned to gain from the rising e-Commerce spending on mobile devices, a profitable domestic market and an under-penetrated international market. We expect these opportunities to continue to drive top-line growth in the long run. Thus, we reiterate our recommendation of Neutral and set a price target of $6.25.”

Groupon Inc (NASDAQ:GRPN) opened at 6.02 on Tuesday. Groupon Inc has a 52 week low of $5.18 and a 52 week high of $12.76. The stock’s 50-day moving average is $6.43 and its 200-day moving average is $7.40. The company’s market cap is $4.029 billion. Groupon also was the target of a large drop in short interest in July. As of July 31st, there was short interest totalling 84,837,914 shares, a drop of 4.0% from the July 15th total of 88,389,748 shares. Approximately 18.6% of the shares of the stock are short sold. Based on an average trading volume of 12,274,217 shares, the days-to-cover ratio is presently 6.9 days.

Groupon, Inc (NASDAQ:GRPN) is a local e-commerce marketplace that connects merchants to consumers by offering goods and services at a discount.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.